PCV13 + Hepatitis A Vaccine for Adults

Clinical trial NCT01926860 · COMPLETED

Trial details

NCT number: NCT01926860
Sponsor: Helsinki University Central Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Measurement of Immune Response to Prevenar13 Measurement of Immune Response to Hepatitis A

Start date: 2013-08-24
Primary completion: 2019-10-28
Enrollment: 305

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.